Cellares

Cellares

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.cellares.com

Last Round

Series D

1/28/2026

Total Funding Raised

$612M

Momentum Score

25 /100

Company Overview

Cellares is a biotechnology company focused on providing integrated development and manufacturing solutions that expedite patient access to life-saving cell therapies.

Sector

Healthcare & Life Sciences

Verticals

Smart Manufacturing, Biotechnology, Pharma Supply Chain, Biotech Equipment, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Hardware + Subscription

AI Layer

Non-AI

Keywords

cell therapy manufacturingIntegrated Development and Manufacturing OrganizationIDMOautomated manufacturingCell ShuttlecGMP manufacturingcell and gene therapy manufacturingCGT manufacturingfactory-in-a-boxcell therapy CDMOsmart factoryCAR-T manufacturingbioprocessing automationclosed manufacturing systemclinical-scale manufacturingcommercial-scale manufacturingprocess developmentautomated quality control

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellares Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cellares Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series D1/28/2026
IPO12/1/2025
Series D1/28/2024
Series C8/23/2023
Series B5/5/2021
Series A
8/1/2019

Key People

Founding team and executive leadership

Fabian Gerlinghaus

Co-Founder CEO

Founding Team

Ossama Eissa

Chief Operating Officer

Executive Team

Cellares Investors

Notable investors and investment history

InvestorRounds
EcoR1 CapitalSeries A
Skyviews Life ScienceSeries B
Duquesne Family OfficeSeries D
Koch-ventures.comSeries C
EDBISeries D
Eclipse VenturesSeries C, Series B, Series A, Series D
Decheng CapitalSeries C, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 30, 2026

    $600 million investment into automated smart factories.

  • Jan 28, 2026

    $257M round raised

Cellares Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cellares Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cellares's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range293
Year Founded2019
Last Funding1/28/2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.